BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17269968)

  • 41. Mycosis fungoides of the mastoid, middle ear, and CNS. Literature review of mycosis fungoides of the CNS.
    Zackheim HS; Lebo CF; Wasserstein P; McNutt NS; Epstein EH; Meyler S; Rosenbaum EH; Grekin DA
    Arch Dermatol; 1983 Apr; 119(4):311-8. PubMed ID: 6838236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell adhesion molecule 1 expression in mycosis fungoides versus parapsoriasis versus inflammatory dermatosis: an immunohistochemical comparative study.
    Neinaa YME; El-Maadawy IH; Atteia IA; Mohamed DAE
    Arch Dermatol Res; 2023 Oct; 315(8):2403-2411. PubMed ID: 36943432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. UVB in the management of early stage mycosis fungoides.
    Pavlotsky F; Barzilai A; Kasem R; Shpiro D; Trau H
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):565-72. PubMed ID: 16684285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Skin directed therapy for mycosis fungoides: a review.
    Berthelot C; Rivera A; Duvic M
    J Drugs Dermatol; 2008 Jul; 7(7):655-66. PubMed ID: 18664158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides.
    Hofer A; Cerroni L; Kerl H; Wolf P
    Arch Dermatol; 1999 Nov; 135(11):1377-80. PubMed ID: 10566837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence rate of mycosis fungoides in Isfahan (Iran).
    Salehi M; Azimi Z; Fatemi F; Rajabi P; Kazemi M; Amini G
    J Dermatol; 2010 Aug; 37(8):703-7. PubMed ID: 20649711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K; Rogers S; McNicholas PD; Collins P
    Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical management of mycosis fungoides.
    Lambert WC; Cohen PJ; Schwartz RA
    J Med; 1997; 28(3-4):211-22. PubMed ID: 9355025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Parapsoriasis en plaques for over 10 years. Evolution towards mycosis fungioides. Appearance of alopecia areas on the plaques and in the extended peripheral zones].
    de Graciansky P; Leclercq R; Boulle M
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(3):301-2. PubMed ID: 5405293
    [No Abstract]   [Full Text] [Related]  

  • 52. [Do you classify parapsoriasis en plaques as mycosis fungoides?].
    Ann Dermatol Venereol; 1993; 120(12):935-8. PubMed ID: 8074362
    [No Abstract]   [Full Text] [Related]  

  • 53. Mycosis fungoides masquerading as cutaneous lupus erythematosus and associated with antiphospholipid syndrome.
    Veysey EC; Wilkinson JD
    Clin Exp Dermatol; 2008 Jan; 33(1):26-9. PubMed ID: 17979989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation between mycosis fungoides and pregnancy.
    Fatemi Naeini F; Abtahi-Naeini B; Najafian J; Saffaei A; Pourazizi M
    Saudi Med J; 2016 Sep; 37(9):968-72. PubMed ID: 27570852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parapsoriasis and mycosis fungoides: the Northwestern University experience, 1970 to 1985.
    Lazar AP; Caro WA; Roenigk HH; Pinski KS
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):919-23. PubMed ID: 2808827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical heterogeneity of poikilodermatous mycosis fungoides: A retrospective study of 12 cases].
    Rohmer E; Mitcov M; Cribier B; Lipsker D; Lenormand C
    Ann Dermatol Venereol; 2020; 147(6-7):418-428. PubMed ID: 32229035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Topical interferon-beta: an additional treatment for ulcerated mycosis fungoides].
    Ständer H; Ständer S; Luger T; Schwarz T
    Hautarzt; 2001 Oct; 52(10):882-4. PubMed ID: 17690818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
    Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
    Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current possibilities of the differential diagnosis of plaque parapsoriasis and the early stages of mycosis fungoides].
    Olisova OY; Grekova EV; Varshavsky VA; Gorenkova LG; Alekseeva EA; Zaletaev DV; Sydikov AA
    Arkh Patol; 2019; 81(1):9-17. PubMed ID: 30830099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
    Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.